Detailed information for compound 629026

Basic information

Technical information
  • TDR Targets ID: 629026
  • Name: N'-(4-fluoro-1,3-benzothiazol-2-yl)-2,6-dimet hoxybenzohydrazide
  • MW: 347.364 | Formula: C16H14FN3O3S
  • H donors: 2 H acceptors: 2 LogP: 3.91 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cccc(c1C(=O)NNc1sc2c(n1)c(F)ccc2)OC
  • InChi: 1S/C16H14FN3O3S/c1-22-10-6-4-7-11(23-2)13(10)15(21)19-20-16-18-14-9(17)5-3-8-12(14)24-16/h3-8H,1-2H3,(H,18,20)(H,19,21)
  • InChiKey: KFLFNRGBLSTXPK-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N'-(4-fluoro-1,3-benzothiazol-2-yl)-2,6-dimethoxy-benzohydrazide
  • ZINC04121348

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis ap endonuclease, putative 0.004 0.016 0.016
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0093 0.2094 0.4957
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0309 1 1
Echinococcus granulosus DNA apurinic or apyrimidinic site lyase 0.004 0.016 0.0571
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0083 0.1754 0.2515
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0095 0.2179 0.7788
Brugia malayi Thioredoxin reductase 0.0037 0.0042 0.0151
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0095 0.2179 0.7301
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0309 1 1
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0226 0.6971 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0309 1 1
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0093 0.2094 0.3003
Echinococcus granulosus thioredoxin glutathione reductase 0.0037 0.006 0.0215
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0095 0.2179 0.7301
Trypanosoma cruzi apurinic/apyrimidinic endonuclease, putative 0.004 0.016 1
Echinococcus multilocularis DNA (apurinic or apyrimidinic site) lyase 0.004 0.016 0.0571
Mycobacterium leprae PROBABLE NADH DEHYDROGENASE NDH 0.0083 0.1754 0.4152
Schistosoma mansoni transcription factor LCR-F1 0.0112 0.2798 0.9375
Trypanosoma brucei apurinic/apyrimidinic endonuclease, putative 0.004 0.016 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0095 0.2179 0.7788
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative 0.0309 1 1
Schistosoma mansoni hypothetical protein 0.0112 0.2798 0.9375
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0095 0.2179 1
Echinococcus multilocularis thioredoxin glutathione reductase 0.0037 0.006 0.0215
Trypanosoma cruzi trypanothione reductase, putative 0.0037 0.0042 0.2643
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0095 0.2179 0.7788
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0309 1 1
Onchocerca volvulus 0.0035 0 0.5
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0083 0.1754 0.2515
Mycobacterium tuberculosis Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) 0.004 0.016 0.0229
Loa Loa (eye worm) glutathione reductase 0.0037 0.0042 0.0194
Trichomonas vaginalis ap endonuclease, putative 0.004 0.016 0.016
Loa Loa (eye worm) exodeoxyribonuclease III family protein 0.004 0.016 0.0733
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0112 0.2798 1
Schistosoma mansoni ap endonuclease 0.004 0.016 0.0535
Mycobacterium tuberculosis Probable reductase 0.0083 0.1754 0.2515
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0309 1 1
Mycobacterium ulcerans exodeoxyribonuclease III protein XthA 0.004 0.016 0.0378
Trypanosoma brucei trypanothione reductase 0.0037 0.0042 0.2643
Entamoeba histolytica hypothetical protein 0.0112 0.2798 0.2681
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0309 1 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0095 0.2179 0.7301
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0112 0.2798 1
Giardia lamblia Fructose-bisphosphate aldolase 0.0309 1 1
Mycobacterium tuberculosis Probable fructose-bisphosphate aldolase Fba 0.0151 0.4223 0.6058
Plasmodium vivax AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.004 0.016 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0309 1 1
Toxoplasma gondii thioredoxin reductase 0.0037 0.0042 0.2643
Mycobacterium tuberculosis Probable dehydrogenase 0.0083 0.1754 0.2515
Brugia malayi glutathione reductase 0.0037 0.0042 0.0151
Loa Loa (eye worm) thioredoxin reductase 0.0037 0.0042 0.0194
Entamoeba histolytica hypothetical protein 0.0112 0.2798 0.2681
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0095 0.2179 0.7788
Brugia malayi hypothetical protein 0.0112 0.2798 1
Schistosoma mansoni ap endonuclease 0.004 0.016 0.0535
Entamoeba histolytica hypothetical protein 0.0112 0.2798 0.2681
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0037 0.0042 0.0061
Onchocerca volvulus 0.0035 0 0.5
Toxoplasma gondii exonuclease III APE 0.004 0.016 1
Plasmodium falciparum AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.004 0.016 1
Plasmodium vivax thioredoxin reductase, putative 0.0037 0.0042 0.2643
Mycobacterium leprae Probable fructose bisphosphate aldolase Fba 0.0151 0.4223 1
Brugia malayi exodeoxyribonuclease III family protein 0.004 0.016 0.0571
Onchocerca volvulus 0.0035 0 0.5
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0083 0.1754 0.2515
Entamoeba histolytica hypothetical protein 0.0112 0.2798 0.2681
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0309 1 1
Wolbachia endosymbiont of Brugia malayi exonuclease III 0.004 0.016 0.5
Leishmania major apurinic/apyrimidinic endonuclease-redox protein 0.004 0.016 1
Treponema pallidum fructose-bisphosphate aldolase 0.0309 1 1
Mycobacterium tuberculosis Probable oxidoreductase 0.0093 0.2094 0.3003
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0093 0.2094 0.3003
Leishmania major trypanothione reductase 0.0037 0.0042 0.2643
Trypanosoma cruzi apurinic/apyrimidinic endonuclease 0.004 0.016 1
Plasmodium vivax glutathione reductase, putative 0.0037 0.0042 0.2643
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0083 0.1754 0.2515
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0095 0.2179 0.7788
Mycobacterium ulcerans fructose-bisphosphate aldolase 0.0151 0.4223 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.